Cargando…

Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer

INTRODUCTION: Manual interpretation of immunohistochemistry (IHC) is a subjective, time-consuming and variable process, with an inherent intra-observer and inter-observer variability. Automated image analysis approaches offer the possibility of developing rapid, uniform indicators of IHC staining. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rexhepaj, Elton, Brennan, Donal J, Holloway, Peter, Kay, Elaine W, McCann, Amanda H, Landberg, Goran, Duffy, Michael J, Jirstrom, Karin, Gallagher, William M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2614526/ https://www.ncbi.nlm.nih.gov/pubmed/18947395 http://dx.doi.org/10.1186/bcr2187

Ejemplares similares

Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer
por: Rexhepaj, Elton, et al.
Publicado: (2010)

The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation
por: Sernbo, Sandra, et al.
Publicado: (2011)

Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer
por: O´Leary, Patrick C, et al.
Publicado: (2013)

Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer
por: Brennan, Donal J, et al.
Publicado: (2010)

The role of oestrogen and progesterone receptors in gigantomastia
por: Kasielska-Trojan, Anna, et al.
Publicado: (2019)

Oestrogen and progesterone receptor distribution in the cancerous breast.
por: Panahy, C., et al.
Publicado: (1987)

Prognostic ability of a panel of immunohistochemistry markers – retailoring of an 'old solution'
por: Brennan, Donal J, et al.
Publicado: (2008)

The role of oestrogen and progesterone receptors in breast cancer – immunohistochemical evaluation of oestrogen and progesterone receptor expression in invasive breast cancer in women
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2015)

Oestrogen increases S-phase fraction and oestrogen and progesterone receptors in human cervical cancer in vivo.
por: Bhattacharya, D., et al.
Publicado: (1997)

Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling
por: Harrison, Hannah, et al.
Publicado: (2013)

Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus
por: Lee, Shi Hao, et al.
Publicado: (2022)

Alcohol consumption and breast cancer oestrogen and progesterone receptor status
por: Enger, S M, et al.
Publicado: (1999)

Intrathoracic myolipoma from parietal pleura with oestrogen and progesterone receptor
por: Teh, Jyh Shinn, et al.
Publicado: (2021)

Author Correction: Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus
por: Lee, Shi Hao, et al.
Publicado: (2023)

Oestrogen and progesterone cytosolic receptors in clinically inflammatory tumours of the human breast.
por: Delarue, J. C., et al.
Publicado: (1981)

Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas
por: Reich, O, et al.
Publicado: (2000)

The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast.
por: Howat, J. M., et al.
Publicado: (1985)

Oestrogen and progesterone receptors and disease-free interval in primary breast cancer.
por: Alanko, A., et al.
Publicado: (1984)

Progesterone regulation of implantation-related genes: new insights into the role of oestrogen
por: Dassen, H., et al.
Publicado: (2007)

Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray
por: Möllerström, Elin, et al.
Publicado: (2010)

Expression of oestrogen and progesterone receptors in gastric cancer: a flow cytometric study
por: Karat, D, et al.
Publicado: (1999)

Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
por: Vermij, Lisa, et al.
Publicado: (2023)

Low ERK Phosphorylation in Cancer-Associated Fibroblasts Is Associated with Tamoxifen Resistance in Pre-Menopausal Breast Cancer
por: Busch, Susann, et al.
Publicado: (2012)

Identification of a myometrial molecular profile for dystocic labor
por: Brennan, Donal J, et al.
Publicado: (2011)

Progesterone receptors – animal models and cell signaling in breast cancer: The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis
por: Anderson, Elizabeth
Publicado: (2002)

The effect of oestrogens, testosterone and progesterone on the induction of cervico-vaginal tumours in intact and castrate rats.
por: Glucksmann, A., et al.
Publicado: (1968)

Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status
por: McCredie, M R E, et al.
Publicado: (2003)

Oestrogen receptor isoforms, their distribution and relation to progesterone receptor levels in breast cancer samples.
por: Baker, V. A., et al.
Publicado: (1992)

Oestrogen receptor negative-progesterone receptor positive phenotype in 1,211 breast tumours.
por: Pichon, M. F., et al.
Publicado: (1992)

The impact of progesterone receptor negativity on oncological outcomes in oestrogen-receptor-positive breast cancer
por: Davey, M G, et al.
Publicado: (2021)

The association of cytosol oestrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease.
por: Howat, J. M., et al.
Publicado: (1983)

Evaluation of Expression of the PTEN Gene, Oestrogen and Progesterone Receptors as Diagnostic and Predictive Factors in Endometrial Cancer
por: Samulak, Dariusz, et al.
Publicado: (2013)

Is oestrogen receptor-negative/progesterone receptor-positive (ER−/PR+) a real pathological entity?
por: Onitilo, Adedayo A, et al.
Publicado: (2021)

Enhanced anti-cancer effects of oestrogen and progesterone co-therapy against colorectal cancer in males
por: Mahbub, Amani A., et al.
Publicado: (2022)

Homeobox transcription factor muscle segment homeobox 2 (Msx2) correlates with good prognosis in breast cancer patients and induces apoptosis in vitro
por: Lanigan, Fiona, et al.
Publicado: (2010)

Diet and body constitution in relation to subgroups of breast cancer defined by tumour grade, proliferation and key cell cycle regulators
por: Borgquist, Signe, et al.
Publicado: (2007)

Adrenal failure in patients with breast carcinoma after long-term treatment of cyclic alternating oestrogen progesterone.
por: Hug, V., et al.
Publicado: (1991)

Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry
por: Work, M E, et al.
Publicado: (2014)

Relationship between the expression of oestrogen receptor and progesterone receptor and (18)F-FDG uptake in endometrial cancer
por: Wu, Chunhua, et al.
Publicado: (2020)

The Role of CHK1 Varies with the Status of Oestrogen-receptor and Progesterone-receptor in the Targeted Therapy for Breast Cancer
por: Xu, Wei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p197ijatfgvile4c4jib7gv5ns